Summit Financial, LLC Genfit S.A. Put Options Transaction History
Summit Financial, LLC
- $6 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
7Shares Held
44.6KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY20.1KShares$85,5100.0% of portfolio
-
Ubs Group Ag5.45KShares$23,1580.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ225Shares$9560.0% of portfolio
-
Principal Securities, Inc. Des Moines, IA24Shares$1020.0% of portfolio
-
Rhumbline Advisers Boston, MA5Shares$210.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $212M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...